NASAL PHYTO
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- Undisclosed
Investors
- 2
About NASAL PHYTO
Based in Shenzhen, China and founded in 2019, NASAL PHYTO is a biotechnology and pharmaceutical company that focuses on development of innovative drugs for central nervous system diseases. The company has a R&D carrier platform and Innovation Center in Zhangjiang, and an Instrumentation Center in Shenzhen. It also cooperated with the Brain Drug Delivery Laboratory in Nanning. The company was awarded Shanghai Innovative Small and Medium-sized Enterprises of 2022. NASAL PHYTO's main product category is a nasal drug delivery system for animals. Products within include Nasal-TDI, a series of innovative devices for precise olfactory spraying and dripping, NPRD003, a new and improved drug against cerebrovascular accidents, NPRD002, a new and improved antidepressant, NPRD004, a new and improved anticancer peptide, and NPRD001, a new and improved anti-Parkinson's Nasal Nano Class I drug. The RA-IDDS and Nasal-TDI drug delivery technology, which can be applied to preclinical basic research, and the solution of small dosage, unstable absorption, poor adaptability, poor parallelism and poor operability. The product can be used in the treatment of neurodegenerative diseases, psychoneurological diseases, strokes, brain tumors and other diseases.S.-China clinical studies in early 2024.
Who invested in NASAL PHYTO
2 investors across 1 round
See all investors in NASAL PHYTO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 21, 2023
Amount
Undisclosed
Investors
Questions about NASAL PHYTO
Who invested in NASAL PHYTO?
NASAL PHYTO has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NASAL PHYTO raised?
NASAL PHYTO has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NASAL PHYTO last raise money?
NASAL PHYTO's most recent round on record is a Series A, in Sep 2023.
What does NASAL PHYTO do?
Based in Shenzhen, China and founded in 2019, NASAL PHYTO is a biotechnology and pharmaceutical company that focuses on development of innovative drugs for central nervous system diseases.
Where is NASAL PHYTO headquartered?
NASAL PHYTO is headquartered in Shenzhen, China.
Which VCs invest in companies like NASAL PHYTO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at NASAL PHYTO's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like NASAL PHYTO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.